Anti-FcγRIIB (CD32) Antibodies Differentially Modulate Murine FVIII-Specific Recall Response in vitro

Area of Science:

• Immunology
• Molecular Biology
• Hematology

Background:

• Fc gamma receptors (FcγRs) regulate adaptive immunity via activating and inhibitory signaling pathways.
• Previous studies in a hemophilia A mouse model indicated that blocking the inhibitory FcγR (CD32) suppresses antibody-secreting cell (ASC) formation.
• The precise mechanisms underlying the FVIII-specific recall response remain unclear.

Purpose of the Study:

• To investigate the role of CD32 inhibition in regulating FVIII-specific immune responses.
• To explore how modulating CD32 activity impacts antibody-secreting cell formation and cytokine release.
• To elucidate the signaling pathways involved in memory B cell activation and ASC differentiation.

Main Methods:

• Utilized a hemophilia A mouse model (FVIII-/-).
• Restimulated splenocytes with FVIII in the presence of anti-CD32 monoclonal antibodies (mAbs) with varying activities (antagonistic vs. agonistic).
• Quantified cytokine release (IFN-γ, IL-10) and assessed FVIII-specific ASC formation; investigated FVIII-immune complex binding to dendritic cells.

Main Results:

• Antagonistic anti-CD32 mAb AT128 suppressed FVIII-specific ASC formation and reduced IFN-γ and IL-10 secretion.
• Agonistic anti-CD32 mAbs (AT130-2, AT130-5) and their fragments promoted FVIII-specific ASC formation.
• Data suggest an inhibitory signal upon FVIII-immune complex binding to CD32 is necessary for memory B cell activation and ASC formation.

Conclusions:

• CD32-mediated inhibitory signaling is essential for optimal FVIII-specific memory B cell activation and subsequent ASC formation.
• Lack of CD32 inhibitory signaling (via deletion or antagonistic blockade) impairs T cell stimulation and ASC production.
• Agonistic CD32 stimulation can restore T cell stimulation and ASC formation, highlighting CD32's critical regulatory role.